BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Oct 15, 2025; 16(10): 109080
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.109080
Type 2 diabetes complicated by dry eye syndrome: Analysis of dry eye symptoms, corneal neuropathy, and influencing factors
Wen-Tao Han, Jin Zhao, Wan-Lu Feng, Wen-Ting Ma
Wen-Tao Han, Jin Zhao, Wan-Lu Feng, Wen-Ting Ma, Department of Ophthalmology, Xianyang First People's Hospital, Xianyang 712000, Shaanxi Province, China
Co-first authors: Wen-Tao Han and Wan-Lu Feng.
Author contributions: Han WT and Feng WL contribute equally to this study as co-first authors; Han WT and Zhao J designed the study, collected and analyzed data, and wrote the manuscript; Han WT, Zhao J and Feng WL participated in the study’s conception and data collection; Han WT, Zhao J and Ma WT participated in study design and provided guidance; all authors read and approved the final version.
Institutional review board statement: This study was approved by the Ethic Committee of Xianyang First People's Hospital.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Ting Ma, Department of Ophthalmology, Xianyang First People's Hospital, No. 10 Biyuan Road, Qindu District, Xianyang 712000, Shaanxi Province, China. mwt0228@163.com
Received: June 24, 2025
Revised: August 4, 2025
Accepted: September 16, 2025
Published online: October 15, 2025
Processing time: 113 Days and 2 Hours
Abstract
BACKGROUND

Dry eye, also known as keratoconjunctival dryness, refers to a group of conditions that lead to eye discomfort and visual dysfunction. Being one of the most common complications of diabetes, it can lead to vision loss and, in severe cases, blindness in patients with diabetes.

AIM

To investigate ocular dryness manifestations, assess corneal neuropathy, and identify associated influencing factors in patients with type 2 diabetes (T2D) complicated with comorbid dry eye syndrome (DES).

METHODS

Data from 81 patients with T2D admitted to Xianyang First People’s Hospital between January 2022 and June 2023 (18 months) were retrospectively reviewed. Patients were divided into the DES and non-DES groups. Additionally, 50 individuals who concurrently underwent medical examinations served as the control group. Standardized assessments were conducted, including evaluations using the standard patient evaluation of eye dryness (SPEED) tool, noninvasive tear film breakup time (NIBUT) analysis, and Schirmer I test (SIt) determination of wetting length. Under a corneal confocal microscope, subbasal corneal neuropathy evaluations were conducted to determine the density, length, number, and tortuosity of the main nerves. Associations among SPEED scores, NIBUT, SIt results, and subbasal corneal neuropathy parameters in the DES group were examined. The DES and non-DES groups were further analyzed for differences in baseline characteristics, and potential risk factors for DES in patients with T2D were identified by multivariate logistic regression modeling.

RESULTS

The T2D + DES group showed an increase in the SPEED score, along with a decrease in the NIBUT and SIt wetting length, compared with the non-DES and control groups (P < 0.05); however, no marked inter-group differences were noted for fluorescein staining test scores between T2D + DES group and DES group. Compared with the non-DES groups, the DES group exhibited reductions in density, length, and number of the main nerves, as well as an increase in nerve tortuosity (all P < 0.05), and all these changes were more pronounced in the non-DES group than in the DES group (all P < 0.05). In the DES group, the SPEED score demonstrated a significant negative correlation with nerve density and the length and number of the main nerves but a positive correlation with nerve tortuosity. Conversely, both the NIBUT and SIt wetting length showed a positive association with the density and number of the main nerves; however, the SIt wetting length demonstrated an inverse correlation with nerve tortuosity. Multivariate modeling identified several independent risk factors for DES in T2D, such as age, diabetes duration, lacrimal gland dysfunction, and insufficient insulin secretion, as well as fasting blood glucose and glycated hemoglobin.

CONCLUSION

Patients with T2D are more susceptible to DES. The T2D + DES group exhibited significant reductions in the density, length, and count, along with increased tortuosity, of the main nerve. These corneal nerve changes are also intimately linked to the severity of DES.

Keywords: Type 2 diabetes; Dry eye syndrome; Dry eyes; Corneal neuropathy

Core Tip: Patients with diabetes are more likely to have dry eyes, experience a burning sensation and foreign body sensation, exhibit corneal epithelial changes, and have a significantly higher incidence of dry eye than those without diabetes. In this study, dry eye and corneal neuropathy symptoms were observed in patients with both dry eye and type 2 diabetes, and the correlation between the two was analyzed. This study also actively explored and summarized relevant factors influencing the occurrence of dry eye in patients with diabetes to provide effective preventive treatment and improve patients’ quality of life.